BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1842113)

  • 1. The nucleoside derivatives possessing sedative and hypnotic effects.
    Kimura T; Kuze J; Watanabe K; Yamamoto I; Ueda T; Katagiri N; Kaneko C; Tateoka Y; Kondo S
    Nucleic Acids Symp Ser; 1991; (25):95-6. PubMed ID: 1842113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sedative and hypnotic activities of pyrimidine nucleoside derivatives.
    Kimura T; Teraoka S; Kuze J; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1993; (29):51-2. PubMed ID: 8247791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding affinity of N3-substituted uridine for synaptic membrane and their CNS depressant effects.
    Kimura T; Miki M; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1995; (34):147-8. PubMed ID: 8841595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 6-azauridine analogues possessing sedative and hypnotic effects.
    Kimura T; Watanabe K; Koshigami M; Miyamoto K; Kondo S; Yamamoto I
    Nucleic Acids Symp Ser; 1992; (27):199-200. PubMed ID: 1283907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypnotic activities of N3-benzyl and xylyl substituted arabinofuranosyluracil.
    Kimura T; Chun YS; Ikeda M; Kobana K; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Nucleic Acids Symp Ser; 1997; (37):229-30. PubMed ID: 9586083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system depressant effects of N3-substituted derivatives of deoxyuridine in mice.
    Kimura T; Kuze J; Teraoka S; Watanabe K; Tateoka Y; Kondo S; Ho IK; Yamamoto I
    Biol Pharm Bull; 1996 Jan; 19(1):142-5. PubMed ID: 8820928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and central nervous system depressant effects of N3-substituted 2',3'-O-isopropylideneuridines.
    Yao CS; Kimura T; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 1999 Dec; 47(12):1802-4. PubMed ID: 10748724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-substituted oxopyrimidines and nucleosides: structure-activity relationship for hypnotic activity as central nervous system depressant.
    Yamamoto I; Kimura T; Tateoka Y; Watanabe K; Ho IK
    J Med Chem; 1987 Dec; 30(12):2227-31. PubMed ID: 3681892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central depressant effects of N3-substituted 6-azauridines in mice.
    Koshigami M; Watanabe K; Kimura T; Yamamoto I
    Chem Pharm Bull (Tokyo); 1991 Oct; 39(10):2597-9. PubMed ID: 1725277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypnotic action of N3-substituted arabinofuranosyluracils on mice.
    Kimura T; Yao S; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 2001 Jan; 49(1):111-3. PubMed ID: 11201214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo and in vitro metabolic studies of N3-benzyluridine which exhibits hypnotic activity in mice.
    Kimura T; Yamamoto I; Watanabe K; Tateoka Y; Ho IK
    Res Commun Chem Pathol Pharmacol; 1991 Jan; 71(1):27-48. PubMed ID: 2024063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypnotic activity of N3-benzylthymidine on mice.
    Yamamoto I; Kimura T; Tateoka Y; Watanabe K; Ho IK
    Life Sci; 1987 Dec; 41(26):2791-7. PubMed ID: 3695807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and pharmacological evaluation of N3-substituted thymidine derivatives as central depressants.
    Kimura T; Watanabe K; Tateoka Y; Kondo S; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 1993 Jun; 41(6):1180-2. PubMed ID: 8370114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central effects of N-substituted derivatives of 2,6-dioxopiperidine in mice.
    Tateoka Y; Kimura T; Kamiyama H; Watanabe K; Yamamoto I; Ho IK
    Res Commun Chem Pathol Pharmacol; 1988 Sep; 61(3):315-26. PubMed ID: 3187198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Syntheses and central depressant activity in mice of uracil derivatives. Studies on development of new sedative-hypnotics. II].
    Tateoka Y; Hiramura S; Usami N; Kimura T; Watanabe K; Yamamoto I
    Yakugaku Zasshi; 1992 Jul; 112(7):470-8. PubMed ID: 1432597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uridine receptor: discovery and its involvement in sleep mechanism.
    Kimura T; Ho IK; Yamamoto I
    Sleep; 2001 May; 24(3):251-60. PubMed ID: 11322706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and sedative-hypnotic effects of N3-allyl- and N1-allyl-5,6-substituted 2-thiouracil derivatives in mice.
    DramiƄski M; Turski K; Tateoka Y; Kimura T; Watanabe K; Kondo S; Ho IK; Yamamoto I
    Chem Pharm Bull (Tokyo); 1998 Sep; 46(9):1370-3. PubMed ID: 9775432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of 2,6-piperidinedione derivatives as potentially novel compounds with analgesic and other CNS activities.
    El Batran SA; Osman AE; Ismail MM; El Sayed AM
    Inflammopharmacology; 2006 Mar; 14(1-2):62-71. PubMed ID: 16835715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Synthesis and evaluation of central nervous system activity of new triaza-spirodecanediones].
    Coudert P; Rubat C; Couquelet JM; Bastide J; Bastide P
    Pharm Acta Helv; 1991; 66(5-6):155-9. PubMed ID: 1686098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and hypnotic-sedative activities of N-substituted uracil on mice.
    Maruyama T; Kozai S; Shimizu T; Kimura T; Watanabe K; Yamamoto I
    Nucleic Acids Res Suppl; 2003; (3):25-6. PubMed ID: 14510362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.